Skip to main content
OpenTrials
Completed

NCT Number: NCT01525953

Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis

The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Esophageal Cancer Digestive System Diseases Digestive System Neoplasms Esophageal Diseases Esophageal Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Head and Neck Neoplasms Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Oscar LAMBRET

Lille, 59000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • localized or locally advanced esophageal cancer
  • patient who underwent definite chemoradiation or radiation
  • patient with complete clinical response

Exclusion criteria

  • metastatic disease

Treatment and study plan

Chemotherapy

Drug

Chemotherapy according to standard

Radiotherapy

Radiation

Radiotherapy according to local standard

Primary outcomes

  1. Identification of prognostic factors for overall survival

    Time frame: From date of treatment until death, assessed up to 10 years

    Correlation between survival and baseline,clinical and treatment characteristics

Secondary outcomes

  1. Patterns of treatment failure

    Time frame: From date of treatment until treatment failure, assessed up to 10 years

    Type of recurrence : local, regional, distant.

  2. Disease-free survival

    Time frame: From date of treatment until progression or death, assessed up to 10 years

    Time between the end of treatment and the occurence of progression

Sponsors and collaborators

Lead sponsor

Centre Oscar Lambret

Other

Registry information

Official study title

Predictors of Survival for Complete Clinical Responders to Definite Chemoradiation or Radiation Therapy for Esophageal Cancer

Acronym: CRCRT-EC

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Feb 3, 2012
Registry last updated
Feb 3, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.